| Wanbury’s R&D is recognized by Department of Scientific & Industrial Research (DSIR) and Government of India. Its Formulation team of dedicated scientists and research doctors are into: |
|
 |
|
Pharma Research: Development of ANDAs and finished dosages for regulated markets |
|
| |
|
NDDS: Development of novel platforms for speciality generics and IPR |
|
| |
|
New drug combinations |
|
| |
|
Development of innovative products |
|
|
| Area of Focus |
|
| |
|
Widening DMF pipeline for regulated markets (27 DMF’s). |
|
| |
|
New product introductions for emerging markets |
|
| |
|
Coverage of versatile therapeutic areas . |
|
| |
|
Development of formulations |
|
| |
|
Development of platforms for Novel Drug Delivery for Specialty Generics |
|
| |
|
Creation of facilities for clinical studies and carrying out bio-equivalence studies |
|
| |
|
| New Product Development : |
|
|
* Development of Solid, semi-solid and liquid dosage forms. |
|
|
* SR/ER/MR dosage forms. |
|
|
* Platform technologies (taste masking, modified release tablets, etc). |
|
|
* Value added generics. |
|
|
* Other dosage forms like oral liquids, Dry Syrups, semi-solids, etc. |
|
|
